Details of the Drug Combinations

General Information of This Drug (ID: DM7YPM1)

Drug Name

Enfuvirtide DM7YPM1

Synonyms

Fuzeon; Pentafuside; Enfuvirtide [USAN]; Roche brand of pentafuside; DP178; Dp 178; Peptide T20; T 20; T20 peptide; Fuzeon (TN); T 20 (peptide); T-20; T-20 cpd

Indication

Disease Entry	ICD 11	Status	REF
Human immunodeficiency virus infection	1C62	Approved	[1]
------------------------------------------------------------------------------------

Therapeutic Class

Anti-HIV Agents

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Enfuvirtide + Valproic Acid	DCB6WEX	Valproic Acid	HIV Infections	[2]
Enfuvirtide + Tipranavir	DCCD494	Tipranavir	HIV Infections	[3]
------------------------------------------------------------------------------------

References

1	Combinations of the first and next generations of human immunodeficiency virus (HIV) fusion inhibitors exhibit a highly potent synergistic effect a... J Virol. 2009 Aug;83(16):7862-72.
2	ClinicalTrials.gov (NCT00312546) Study of Valproic Acid to Treat HIV Infected Adults
3	ClinicalTrials.gov (NCT00440271) SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC